These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33676317)

  • 21. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.
    Cheah CS; Lundstrom BN; Catterall WA; Oakley JC
    J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome.
    Cheah CS; Yu FH; Westenbroek RE; Kalume FK; Oakley JC; Potter GB; Rubenstein JL; Catterall WA
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14646-51. PubMed ID: 22908258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model.
    Miljanovic N; Hauck SM; van Dijk RM; Di Liberto V; Rezaei A; Potschka H
    Neurobiol Dis; 2021 Sep; 157():105423. PubMed ID: 34144125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome.
    Dyment DA; Schock SC; Deloughery K; Tran MH; Ure K; Nutter LMJ; Creighton A; Yuan J; Banderali U; Comas T; Baumann E; Jezierski A; ; Boycott KM; Mackenzie AE; Martina M
    Genetics; 2020 Aug; 215(4):1055-1066. PubMed ID: 32554600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticohippocampal circuit dysfunction in a mouse model of Dravet syndrome.
    Mattis J; Somarowthu A; Goff KM; Jiang E; Yom J; Sotuyo N; Mcgarry LM; Feng H; Kaneko K; Goldberg EM
    Elife; 2022 Feb; 11():. PubMed ID: 35212623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome.
    Kalume F; Oakley JC; Westenbroek RE; Gile J; de la Iglesia HO; Scheuer T; Catterall WA
    Neurobiol Dis; 2015 May; 77():141-54. PubMed ID: 25766678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective Na
    Richards KL; Milligan CJ; Richardson RJ; Jancovski N; Grunnet M; Jacobson LH; Undheim EAB; Mobli M; Chow CY; Herzig V; Csoti A; Panyi G; Reid CA; King GF; Petrou S
    Proc Natl Acad Sci U S A; 2018 Aug; 115(34):E8077-E8085. PubMed ID: 30076230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome.
    Tai C; Abe Y; Westenbroek RE; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3139-48. PubMed ID: 25024183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal and generalized seizure activity after local hippocampal or cortical ablation of Na
    Jansen NA; Dehghani A; Breukel C; Tolner EA; van den Maagdenberg AMJM
    Epilepsia; 2020 Apr; 61(4):e30-e36. PubMed ID: 32190912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome.
    Anderson LL; Hawkins NA; Thompson CH; Kearney JA; George AL
    Sci Rep; 2017 May; 7(1):1682. PubMed ID: 28490751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome.
    Goff KM; Goldberg EM
    Elife; 2019 Jul; 8():. PubMed ID: 31282864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat induced temperature dysregulation and seizures in Dravet Syndrome/GEFS+ Gabrg2
    Warner TA; Liu Z; Macdonald RL; Kang JQ
    Epilepsy Res; 2017 Aug; 134():1-8. PubMed ID: 28505490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K).
    Beretta S; Gritti L; Ponzoni L; Scalmani P; Mantegazza M; Sala M; Verpelli C; Sala C
    Mol Autism; 2022 Jan; 13(1):1. PubMed ID: 34980259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes and comorbidities of SCN1A-related seizure disorders.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau reduction prevents disease in a mouse model of Dravet syndrome.
    Gheyara AL; Ponnusamy R; Djukic B; Craft RJ; Ho K; Guo W; Finucane MM; Sanchez PE; Mucke L
    Ann Neurol; 2014 Sep; 76(3):443-56. PubMed ID: 25042160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiating α
    Nomura T; Hawkins NA; Kearney JA; George AL; Contractor A
    J Physiol; 2019 Aug; 597(16):4293-4307. PubMed ID: 31045243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: a population-based ten-year cohort study.
    Verbeek NE; van der Maas NA; Jansen FE; van Kempen MJ; Lindhout D; Brilstra EH
    PLoS One; 2013; 8(6):e65758. PubMed ID: 23762420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome.
    Ogiwara I; Iwasato T; Miyamoto H; Iwata R; Yamagata T; Mazaki E; Yanagawa Y; Tamamaki N; Hensch TK; Itohara S; Yamakawa K
    Hum Mol Genet; 2013 Dec; 22(23):4784-804. PubMed ID: 23922229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmentally regulated impairment of parvalbumin interneuron synaptic transmission in an experimental model of Dravet syndrome.
    Kaneko K; Currin CB; Goff KM; Wengert ER; Somarowthu A; Vogels TP; Goldberg EM
    Cell Rep; 2022 Mar; 38(13):110580. PubMed ID: 35354025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.